AboutValuesWhy OA.mg?OA.mg PremiumExploreDataContact
Chrome ExtensionScholarMindChatGPT Plugin
ϟ
 
DOI: 10.1016/j.amjcard.2017.05.015
¤ OpenAccess: Hybrid
This work has “Hybrid” OA status. This means it is free under an open license in a toll-access journal.

Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes

Francesco Paneni,Thomas F. Lüscher

Empagliflozin
Medicine
Liraglutide
2017
Loading...
    Cite this:
Generate Citation
Powered by Citationsy*
    “Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes” is a paper by Francesco Paneni Thomas F. Lüscher published in 2017. It has an Open Access status of “hybrid”. You can read and download a PDF Full Text of this paper here.
    OA.mgAbout UsOur ValuesWhy OA.mg? OA.mg PremiumChrome ExtensionChatGPT PluginPublic RoadmapChangelogContact UsFeedback?
    Privacy PolicyTerms of ServiceRefund Policy
    ContentOA.mg CoverageTop ListsOpen Access JournalsTopicsBlog
    ExploreGeographyEngineeringPoliSciGeologyPhilosophySociologyArtHistoryMathematicsPhysics
     PsychologyComputer ScienceBusinessEnvironmental ScienceChemistryMaterials ScienceMedicineBiologyEconomics
    OA.mg is built in Stockholm, London, and Seoul. We work hand in hand with the scientific community to advance the cause of Open Access. Feedback makes us better.